CorriXR Therapeutics

Wilmington, United States

CorriXR Therapeutics is a biotechnology company.

$1.0M raised

Aug 2025

Series A

Biotechnology Health Care Therapeutics

Top Investors

Cortado VenturesSouthern ResearchChristiana Care Health SystemsState of DelawareBrookhaven Bio

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CorriXR Therapeutics

How much funding has CorriXR Therapeutics raised?

CorriXR Therapeutics has raised $1.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.

Who are CorriXR Therapeutics's investors?

CorriXR Therapeutics's investors include Cortado Ventures, Southern Research, Christiana Care Health Systems, State of Delaware, Brookhaven Bio.

Where is CorriXR Therapeutics headquartered?

CorriXR Therapeutics is headquartered in Wilmington, United States.

What does CorriXR Therapeutics do?

CorriXR Therapeutics is a biotechnology company.

What stage is CorriXR Therapeutics at?

CorriXR Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 19, 2025.

MLA

"CorriXR Therapeutics — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/corrixr-therapeutics. Accessed June 9, 2026.

APA

VCBacked. (2025). CorriXR Therapeutics — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/corrixr-therapeutics

Wikipedia (cite web)

{{cite web |title=CorriXR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/corrixr-therapeutics |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 19, 2025.

Similar Companies in Biotechnology